New Delhi, Aug. 22 -- Japanese pharmaceutical giant Takeda Pharmaceutical Co. is actively exploring the possibility of conducting global clinical trials in India, aiming to fast-track the approval and availability of its innovative therapies in one of the world's most populous markets. The announcement was made today by Annapurna Das, head of Takeda's India operations.

Strategic Push into India's Growing Clinical Trials Landscape

India's clinical trials market is experiencing rapid expansion, supported by its diverse patient pools, cost advantages, and rapidly expanding hospital network. For Takeda, this presents a compelling opportunity to integrate India more deeply into its global R&D and drug development ecosystem.

Long-term Invest...